Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laser Therapy | 20 | 2022 | 1072 | 3.200 |
Why?
|
| Lasers, Gas | 6 | 2024 | 93 | 2.850 |
Why?
|
| Skin | 23 | 2024 | 4364 | 1.810 |
Why?
|
| Skin Aging | 6 | 2022 | 127 | 1.420 |
Why?
|
| Lipectomy | 3 | 2022 | 118 | 1.360 |
Why?
|
| Lasers, Solid-State | 2 | 2022 | 169 | 1.250 |
Why?
|
| Cryosurgery | 2 | 2022 | 453 | 0.830 |
Why?
|
| Cutis Laxa | 1 | 2020 | 29 | 0.740 |
Why?
|
| Hyperemia | 1 | 2021 | 225 | 0.720 |
Why?
|
| Tomography, Optical Coherence | 4 | 2021 | 2657 | 0.710 |
Why?
|
| Microvessels | 2 | 2021 | 544 | 0.710 |
Why?
|
| Dermatology | 2 | 2022 | 872 | 0.700 |
Why?
|
| Capillaries | 2 | 2019 | 773 | 0.690 |
Why?
|
| Skin Ulcer | 2 | 2018 | 120 | 0.680 |
Why?
|
| Lasers, Semiconductor | 2 | 2009 | 46 | 0.680 |
Why?
|
| Chalcogens | 1 | 2018 | 3 | 0.660 |
Why?
|
| Angiography | 2 | 2021 | 1639 | 0.640 |
Why?
|
| Adipocytes | 2 | 2018 | 1184 | 0.630 |
Why?
|
| Epidermis | 4 | 2022 | 528 | 0.600 |
Why?
|
| Microcirculation | 1 | 2021 | 1286 | 0.570 |
Why?
|
| Subcutaneous Fat | 3 | 2022 | 391 | 0.540 |
Why?
|
| Cryotherapy | 3 | 2022 | 155 | 0.540 |
Why?
|
| Lasers | 3 | 2017 | 952 | 0.510 |
Why?
|
| Neutrophil Infiltration | 1 | 2017 | 390 | 0.510 |
Why?
|
| Hot Temperature | 3 | 2011 | 1354 | 0.500 |
Why?
|
| NAD | 1 | 2018 | 593 | 0.490 |
Why?
|
| Photolysis | 2 | 2017 | 92 | 0.440 |
Why?
|
| Dermis | 4 | 2009 | 207 | 0.440 |
Why?
|
| Fibrin | 1 | 2015 | 506 | 0.440 |
Why?
|
| Phototherapy | 5 | 2007 | 377 | 0.440 |
Why?
|
| Burns | 3 | 2016 | 1815 | 0.410 |
Why?
|
| Immunity | 1 | 2017 | 1012 | 0.390 |
Why?
|
| Immunity, Cellular | 1 | 2017 | 1607 | 0.390 |
Why?
|
| Fibroblasts | 3 | 2011 | 4161 | 0.380 |
Why?
|
| Bystander Effect | 1 | 2011 | 81 | 0.380 |
Why?
|
| Microscopy, Fluorescence | 1 | 2018 | 2699 | 0.380 |
Why?
|
| Antigens, Neoplasm | 2 | 2021 | 1988 | 0.370 |
Why?
|
| Surgery, Plastic | 1 | 2017 | 624 | 0.360 |
Why?
|
| Carbon Dioxide | 3 | 2024 | 1150 | 0.340 |
Why?
|
| Sebum | 1 | 2009 | 16 | 0.340 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2009 | 93 | 0.330 |
Why?
|
| Electrocoagulation | 1 | 2008 | 158 | 0.300 |
Why?
|
| Drug Delivery Systems | 3 | 2015 | 2219 | 0.300 |
Why?
|
| Cicatrix | 4 | 2012 | 764 | 0.290 |
Why?
|
| Skin Temperature | 1 | 2007 | 93 | 0.290 |
Why?
|
| Swine | 6 | 2022 | 5917 | 0.280 |
Why?
|
| Melanosis | 1 | 2007 | 78 | 0.270 |
Why?
|
| Ultrasonic Therapy | 1 | 2008 | 235 | 0.270 |
Why?
|
| Periodicals as Topic | 1 | 2017 | 1432 | 0.270 |
Why?
|
| Blood Pressure | 1 | 2021 | 8554 | 0.260 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 2541 | 0.260 |
Why?
|
| Thulium | 2 | 2022 | 21 | 0.260 |
Why?
|
| Face | 2 | 2009 | 994 | 0.250 |
Why?
|
| Neutrophils | 1 | 2017 | 3719 | 0.250 |
Why?
|
| Administration, Cutaneous | 5 | 2024 | 711 | 0.240 |
Why?
|
| Hemangioma | 1 | 2009 | 738 | 0.240 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2017 | 2988 | 0.230 |
Why?
|
| Forearm | 3 | 2021 | 409 | 0.230 |
Why?
|
| Tissue Culture Techniques | 2 | 2018 | 290 | 0.230 |
Why?
|
| Stress, Physiological | 1 | 2011 | 1403 | 0.220 |
Why?
|
| Metalloporphyrins | 1 | 2022 | 41 | 0.220 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2024 | 104 | 0.220 |
Why?
|
| Cell Cycle | 1 | 2011 | 2967 | 0.210 |
Why?
|
| Aging | 1 | 2021 | 8664 | 0.210 |
Why?
|
| Hypertension | 1 | 2021 | 8480 | 0.190 |
Why?
|
| Mice, Inbred BALB C | 4 | 2017 | 6386 | 0.190 |
Why?
|
| DNA Damage | 1 | 2010 | 2432 | 0.180 |
Why?
|
| Melanoma | 3 | 2024 | 5510 | 0.160 |
Why?
|
| 3T3-L1 Cells | 1 | 2018 | 198 | 0.160 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2010 | 876 | 0.160 |
Why?
|
| Phenformin | 1 | 2017 | 16 | 0.150 |
Why?
|
| Skin Neoplasms | 2 | 2024 | 5686 | 0.150 |
Why?
|
| Pilot Projects | 3 | 2021 | 8324 | 0.150 |
Why?
|
| Humans | 42 | 2024 | 744343 | 0.150 |
Why?
|
| Erythema | 3 | 2014 | 257 | 0.140 |
Why?
|
| Neck | 1 | 2020 | 697 | 0.130 |
Why?
|
| Neurofibromin 1 | 1 | 2017 | 196 | 0.130 |
Why?
|
| Fluorescein Angiography | 1 | 2019 | 940 | 0.130 |
Why?
|
| Indazoles | 1 | 2017 | 289 | 0.130 |
Why?
|
| Lymphocyte Count | 1 | 2017 | 793 | 0.130 |
Why?
|
| Apoptosis | 2 | 2017 | 9727 | 0.130 |
Why?
|
| Epitopes | 2 | 2021 | 2571 | 0.120 |
Why?
|
| Animals | 12 | 2022 | 168757 | 0.120 |
Why?
|
| Singlet Oxygen | 1 | 2014 | 53 | 0.120 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 625 | 0.120 |
Why?
|
| Aminolevulinic Acid | 1 | 2014 | 142 | 0.110 |
Why?
|
| Cell Survival | 3 | 2017 | 5882 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 1375 | 0.110 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 16689 | 0.110 |
Why?
|
| Adaptive Immunity | 1 | 2017 | 713 | 0.110 |
Why?
|
| Skin Diseases | 2 | 2014 | 1065 | 0.100 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 18029 | 0.100 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 1038 | 0.100 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2014 | 689 | 0.100 |
Why?
|
| Tumor Burden | 1 | 2017 | 1915 | 0.100 |
Why?
|
| Mice | 7 | 2022 | 81183 | 0.100 |
Why?
|
| Adipose Tissue | 2 | 2017 | 3279 | 0.100 |
Why?
|
| Micronucleus Tests | 1 | 2010 | 23 | 0.090 |
Why?
|
| Female | 15 | 2021 | 380194 | 0.090 |
Why?
|
| Photosensitizing Agents | 1 | 2014 | 602 | 0.090 |
Why?
|
| Biopsy | 2 | 2015 | 6756 | 0.090 |
Why?
|
| Lidocaine | 1 | 2012 | 544 | 0.090 |
Why?
|
| Hyperpigmentation | 2 | 2007 | 112 | 0.080 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2012 | 546 | 0.080 |
Why?
|
| Heat-Shock Response | 1 | 2010 | 165 | 0.080 |
Why?
|
| Wound Healing | 2 | 2013 | 2785 | 0.080 |
Why?
|
| Neoplasms | 1 | 2017 | 21683 | 0.080 |
Why?
|
| Vaccines | 2 | 2014 | 822 | 0.080 |
Why?
|
| Biophysical Phenomena | 1 | 2009 | 327 | 0.080 |
Why?
|
| Culture Media | 1 | 2010 | 908 | 0.080 |
Why?
|
| Forecasting | 1 | 2017 | 2951 | 0.080 |
Why?
|
| Photochemotherapy | 1 | 2014 | 807 | 0.080 |
Why?
|
| Immunization | 1 | 2012 | 1256 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2018 | 2899 | 0.070 |
Why?
|
| Piperazines | 1 | 2017 | 2488 | 0.070 |
Why?
|
| Lentigo | 1 | 2006 | 37 | 0.070 |
Why?
|
| Rejuvenation | 1 | 2007 | 91 | 0.070 |
Why?
|
| Collagen Type III | 1 | 2006 | 90 | 0.070 |
Why?
|
| Cold Temperature | 1 | 2009 | 772 | 0.070 |
Why?
|
| Docosahexaenoic Acids | 1 | 2012 | 875 | 0.070 |
Why?
|
| Anesthetics, Local | 1 | 2012 | 985 | 0.070 |
Why?
|
| Facial Dermatoses | 1 | 2006 | 87 | 0.070 |
Why?
|
| Dermatitis | 1 | 2007 | 197 | 0.060 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2006 | 285 | 0.060 |
Why?
|
| Mitochondria | 1 | 2018 | 3520 | 0.060 |
Why?
|
| Cadaver | 2 | 2007 | 1337 | 0.060 |
Why?
|
| Microscopy, Confocal | 2 | 2013 | 1970 | 0.060 |
Why?
|
| Disease Progression | 1 | 2021 | 13284 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2017 | 10252 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 1 | 2022 | 21827 | 0.060 |
Why?
|
| Colitis | 1 | 2012 | 1170 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2017 | 4479 | 0.060 |
Why?
|
| Infrared Rays | 1 | 2005 | 249 | 0.060 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2006 | 404 | 0.060 |
Why?
|
| Cell Division | 1 | 2011 | 4568 | 0.060 |
Why?
|
| Rhodamines | 2 | 2014 | 183 | 0.050 |
Why?
|
| Partial Pressure | 1 | 2022 | 254 | 0.050 |
Why?
|
| Models, Animal | 1 | 2009 | 2171 | 0.050 |
Why?
|
| Aged | 5 | 2022 | 163280 | 0.050 |
Why?
|
| Cell Communication | 1 | 2010 | 1621 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 1790 | 0.050 |
Why?
|
| Adult | 9 | 2024 | 214055 | 0.050 |
Why?
|
| Fever | 1 | 2010 | 1616 | 0.050 |
Why?
|
| Vaccination | 1 | 2014 | 3278 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 8949 | 0.050 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2006 | 687 | 0.050 |
Why?
|
| Necrosis | 1 | 2006 | 1643 | 0.050 |
Why?
|
| Equipment Design | 1 | 2010 | 3582 | 0.050 |
Why?
|
| Young Adult | 3 | 2021 | 56430 | 0.050 |
Why?
|
| Ovalbumin | 2 | 2014 | 719 | 0.050 |
Why?
|
| Adolescent | 3 | 2024 | 85781 | 0.050 |
Why?
|
| Hair Removal | 1 | 2001 | 42 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2011 | 5974 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2001 | 424 | 0.040 |
Why?
|
| Time Factors | 2 | 2015 | 40075 | 0.040 |
Why?
|
| Cell Line | 2 | 2012 | 15997 | 0.040 |
Why?
|
| Skin Pigmentation | 1 | 2001 | 282 | 0.040 |
Why?
|
| Laser Coagulation | 1 | 2001 | 326 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2008 | 5078 | 0.040 |
Why?
|
| Actins | 1 | 2006 | 2121 | 0.040 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2017 | 94 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2022 | 63114 | 0.040 |
Why?
|
| Phase Transition | 1 | 2017 | 74 | 0.040 |
Why?
|
| Melanocytes | 1 | 2021 | 515 | 0.040 |
Why?
|
| Macrophages | 1 | 2012 | 5655 | 0.040 |
Why?
|
| Lipids | 1 | 2008 | 3305 | 0.040 |
Why?
|
| Europe | 1 | 2024 | 3339 | 0.040 |
Why?
|
| Middle Aged | 8 | 2012 | 213383 | 0.040 |
Why?
|
| Communicable Disease Control | 1 | 2024 | 857 | 0.040 |
Why?
|
| Regeneration | 1 | 2006 | 1485 | 0.040 |
Why?
|
| Carbon Monoxide | 1 | 2020 | 531 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 57776 | 0.030 |
Why?
|
| Obesity | 1 | 2018 | 12745 | 0.030 |
Why?
|
| Pharmaceutical Preparations | 1 | 2024 | 1071 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2011 | 19229 | 0.030 |
Why?
|
| Injections, Intradermal | 1 | 2014 | 117 | 0.030 |
Why?
|
| Male | 8 | 2017 | 350118 | 0.030 |
Why?
|
| Pain | 1 | 2009 | 4986 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2024 | 1859 | 0.030 |
Why?
|
| Microinjections | 1 | 2014 | 327 | 0.030 |
Why?
|
| Protoporphyrins | 1 | 2014 | 164 | 0.030 |
Why?
|
| Dermabrasion | 1 | 2013 | 13 | 0.030 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2013 | 37 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2017 | 1792 | 0.030 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2017 | 721 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 11366 | 0.030 |
Why?
|
| Injections, Intralesional | 1 | 2012 | 276 | 0.030 |
Why?
|
| Methylene Blue | 1 | 2012 | 155 | 0.020 |
Why?
|
| Needles | 1 | 2014 | 449 | 0.020 |
Why?
|
| Temperature | 1 | 2017 | 2206 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2013 | 553 | 0.020 |
Why?
|
| Abdominal Wall | 1 | 2012 | 157 | 0.020 |
Why?
|
| Oxygen | 1 | 2022 | 4189 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 407 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2013 | 391 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2017 | 1869 | 0.020 |
Why?
|
| Artifacts | 1 | 2019 | 1904 | 0.020 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2013 | 434 | 0.020 |
Why?
|
| Kinetics | 1 | 2017 | 6473 | 0.020 |
Why?
|
| Adjuvants, Immunologic | 1 | 2014 | 1000 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2013 | 721 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2012 | 1590 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2009 | 40561 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2012 | 1539 | 0.020 |
Why?
|
| Antigens | 1 | 2012 | 1466 | 0.020 |
Why?
|
| Electrons | 1 | 2006 | 268 | 0.020 |
Why?
|
| Pigmentation Disorders | 1 | 2006 | 101 | 0.020 |
Why?
|
| Collagen | 1 | 2013 | 2689 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 4217 | 0.010 |
Why?
|
| Pandemics | 1 | 2024 | 8388 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2006 | 15295 | 0.010 |
Why?
|
| Acne Vulgaris | 1 | 2007 | 302 | 0.010 |
Why?
|
| Pressure | 1 | 2006 | 1203 | 0.010 |
Why?
|
| Japan | 1 | 2006 | 1360 | 0.010 |
Why?
|
| Congresses as Topic | 1 | 2006 | 764 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2013 | 4554 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 2001 | 719 | 0.010 |
Why?
|
| Algorithms | 1 | 2019 | 13881 | 0.010 |
Why?
|
| Prospective Studies | 3 | 2007 | 53288 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2007 | 3420 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2007 | 3396 | 0.010 |
Why?
|
| Mutation | 1 | 2017 | 29786 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 35421 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 15540 | 0.010 |
Why?
|
| Models, Biological | 1 | 2005 | 9583 | 0.010 |
Why?
|
| Risk Factors | 1 | 2007 | 72290 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2007 | 77449 | 0.000 |
Why?
|
Concepts
(227)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(33)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_